Your browser doesn't support javascript.
loading
First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.
Angevin, Eric; Isambert, Nicolas; Trillet-Lenoir, Véronique; You, Benoit; Alexandre, Jérôme; Zalcman, Gérard; Vielh, Philippe; Farace, Françoise; Valleix, Fanny; Podoll, Thomas; Kuramochi, Yu; Miyashita, Itaru; Hosono, Osamu; Dang, Nam H; Ohnuma, Kei; Yamada, Taketo; Kaneko, Yutaro; Morimoto, Chikao.
Afiliação
  • Angevin E; Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, France.
  • Isambert N; Centre Georges-François Leclerc, Unité de Phases Précoces, Dijon, France.
  • Trillet-Lenoir V; Institut de Cancérologie des Hospices Civils de Lyon, CITOHL, Lyon, France.
  • You B; Institut de Cancérologie des Hospices Civils de Lyon, CITOHL, Lyon, France.
  • Alexandre J; Hôpital Cochin, Paris, France.
  • Zalcman G; Centre Hospitalier Universitaire (CHU) de Caen, Centre de Recherche Clinique/Essais de phases précoces, Caen, France.
  • Vielh P; Gustave Roussy, Translational Research Laboratory, Villejuif, France.
  • Farace F; Gustave Roussy, Translational Research Laboratory, Villejuif, France.
  • Valleix F; FV Clinical subcontractor for SynteractHCR SAS, Levallois-Perret, France.
  • Podoll T; Y's therapeutics Inc., Redwood City, CA, USA.
  • Kuramochi Y; Kissei Pharmaceutical Co., Ltd, Tokyo, Japan.
  • Miyashita I; Kissei Pharmaceutical Co., Ltd, Tokyo, Japan.
  • Hosono O; Department of Rheumatology and Allergy, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Dang NH; Division of Hematology/Oncology, University of Florida, Gainesville, FL, USA.
  • Ohnuma K; Department of Therapy Development and Innovation for Immune Disorders and Cancers, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Yamada T; Keio University School of Medicine, Tokyo, Japan.
  • Kaneko Y; Saitama Medical University, Saitama, Japan.
  • Morimoto C; Y's AC Co., Ltd, Tokyo, Japan.
Br J Cancer ; 116(9): 1126-1134, 2017 Apr 25.
Article em En | MEDLINE | ID: mdl-28291776
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Dipeptidil Peptidase 4 / Mesotelioma / Anticorpos Monoclonais Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Dipeptidil Peptidase 4 / Mesotelioma / Anticorpos Monoclonais Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido